Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
Go back to Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 16.21 -0.07 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.28 | 52 Week High | $0.19 | |||
| Open | $16.47 | 52 Week Low | $0.07 | |||
| Day High | $16.61 | P/E | N/A | |||
| Day Low | $15.73 | EPS | $-0.01 | |||
| Volume | 2,874,909 | |||||
